Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives
- PMID: 33223770
- PMCID: PMC7666603
- DOI: 10.2337/ds19-0039
Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives
Abstract
The purpose of this study was to determine clinician attitudes about the distinct barriers to uptake of continuous glucose monitoring (CGM) among people with diabetes. Survey data were collected measuring individual barriers, prerequisites to CGM, confidence in addressing barriers, and clinic staff resources. Results show that clinicians commonly report barriers to using CGM among people with diabetes in their clinic. Furthermore, clinicians who report a high number of barriers do not feel confident in overcoming the barriers to CGM. Interventions that attempt to empower clinicians to address concerns about CGM among people with diabetes may be warranted because low uptake does not appear to be directly related to available resources or prerequisites to starting CGM.
© 2020 by the American Diabetes Association.
References
-
- Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26:1079–1087 - PubMed
-
- Lukács A, Sasvári P, Török A, Barkai L. Generic and disease-specific quality of life in adolescents with type 1 diabetes: comparison to age-matched healthy peers. J Pediatr Endocrinol Metab 2016;29:769–775 - PubMed
LinkOut - more resources
Full Text Sources
Medical